Literature DB >> 16903842

Active warming as emergency interventional care for the treatment of pelvic pain.

P Bertalanffy1, A Kober, H Andel, R Hahn, N Frickey, K Hoerauf.   

Abstract

OBJECTIVE: To assess whether local active warming can lessen acute pelvic pain of gynaecological origin compared with traditional methods in a prehospital setting.
DESIGN: Prospective, randomised, single-blinded study. Setting. Prehospital emergency system. Population. Women calling emergency ambulance for pelvic pain.
METHODS: Women were randomised in two groups: resistive heating (group 1) or passive warming (group 2), each treatment was initiated at the emergency site. MAIN OUTCOME MEASURES: Pain on visual analogue scale (VAS), anxiety and nausea, given as mean (SD).
RESULTS: Prior to the interventions, all women were vasoconstricted and had comparable pain scores. Then, group 1 showed a significant (P < 0.01) reduction in pain (VAS: 72.2 [10.5] mm to 32.4 [18.0] mm), anxiety (VAS: 59.0 [10.9] mm to 37.5 [24.1] mm), nausea (VAS: 42.7 [6.2] mm to 21.6 [5.0] mm) and heart rate (101 [12] beats per minute [bpm] to 59 [8] bpm), as well as in the number of vasoconstricted women (from 19/19 (constricted/dilated) to 2/19 (constricted/dilated)), whereas scores in group 2 remained unchanged. There were no significant changes in blood pressure in either group.
CONCLUSIONS: Local warming is an effective emergency care measure for acute pelvic pain.

Entities:  

Mesh:

Year:  2006        PMID: 16903842     DOI: 10.1111/j.1471-0528.2006.01030.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  2 in total

1.  Warm distension fluid reduces pain severity in office hysteroscopy: a randomized controlled trial.

Authors:  Selim Gulucu; Bulent Cakmak
Journal:  Ann Saudi Med       Date:  2021-06-01       Impact factor: 1.526

Review 2.  Nonpharmacological interventions for pain management in paramedicine and the emergency setting: a review of the literature.

Authors:  Sok Cheon Pak; Peter S Micalos; Sonja J Maria; Bill Lord
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-31       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.